Adma Biologics (ADMA) Profit Margin (2012 - 2026)
Adma Biologics (ADMA) profit margin from Jun 30, 2012 to Mar 31, 2026. The current Adma Biologics (ADMA) profit margin is 39.59%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Adma Biologics (ADMA)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 28.80% | -37.87% |
| 2024 | 46.35% | -523.82% |
| 2023 | -10.94% | -74.43% |
| 2022 | -42.77% | -51.68% |
| 2021 | -88.52% | -50.66% |
| 2020 | -179.42% | +9.07% |
| 2019 | -164.50% | -57.49% |
| 2018 | -386.93% | +38.11% |
| 2017 | -280.15% | +50.98% |
| 2016 | -185.55% | -27.20% |
| 2015 | -254.89% | -11.45% |
| 2014 | -287.84% | -44.03% |
| 2013 | -514.24% | -21.10% |
| 2012 | -651.79% | -16.04% |
| 2011 | -776.32% | N/A |
Comparison Adma Biologics (ADMA) profit margin with competitors
Adma Biologics (ADMA) profit margin is 39.59%.